CompletedNot Applicable

Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure

Vietnam71 participantsStarted 2011-03

Plain-language summary

Atosiban, administered at embryo transfer, can improve the implantation rate and the clinical pregnancy rate in patients with repeated implantation failure undergoing IVF-ET (in-vitro fertilization and embryo transfer).

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * had repeated implantation failure * have at least 1 good quality embryo for transfer Exclusion Criteria: * uterine abnormalities that could compromise the implantation process (e.g. fibroids, endometrial polyp, bicornuate uterus, adhesion of uterine cavity)

What they're measuring

Clinical pregnancy

Timeframe: 5 weeks after intervention

Trial details

NCT IDNCT01493440

SponsorAn Sinh Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-08

View on ClinicalTrials.gov More Repeated Implantation Failure trials